Proteostasis Therapeutics, Inc. Announces Closing of Initial Public Offering
February 18 2016 - 6:30AM
Proteostasis Therapeutics, Inc. today announced the closing of its
initial public offering of 6,250,000 shares of common stock at a
public offering price of $8.00 per share. All of the shares sold in
the offering were offered by Proteostasis Therapeutics, Inc. The
company’s shares began trading on the NASDAQ Global Market on
February 11, 2016 under the ticker symbol “PTI.” The gross proceeds
from the offering are $50.0 million, before deducting underwriting
discounts and commissions and expenses associated with the offering
payable by the company.
Leerink Partners and RBC Capital Markets acted as joint
book-running managers. Baird and H.C. Wainwright & Co. acted as
co-managers.
A registration statement relating to the securities being sold
in the offering was declared effective by the Securities and
Exchange Commission on February 10, 2016. This offering is being
made only by means of a prospectus. Copies of the final prospectus
relating to this offering may be obtained by contacting: Leerink
Partners LLC, Attention: Syndicate Department, One Federal Street,
37th Floor, Boston, MA 02110, or by email
at syndicate@leerink.com, or by phone at (800) 808-7525, ext.
6142; or RBC Capital Markets, LLC, Attention: Equity Syndicate, 200
Vesey Street, 8th Floor, New York, NY 10281, Telephone: (877)
822-4089, Email: equityprospectus@rbccm.com.
This press release shall not constitute an offer to sell or the
solicitation of an offer to buy, nor shall there be any sale of
these securities in any state or jurisdiction in which such offer,
solicitation or sale would be unlawful prior to registration or
qualification under the securities laws of any such state or
jurisdiction.
Media Contact:
Dan Budwick, Pure Communications
dan@purecommunicationsinc.com
973-271-6085
Investor Contact:
Luke Heagle, Pure Communications
luke@purecommunicationsinc.com
910-726-1372
Proteostasis Therapeutics (NASDAQ:PTI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Proteostasis Therapeutics (NASDAQ:PTI)
Historical Stock Chart
From Apr 2023 to Apr 2024